NCT07232680 (IMPRINT) is a clinical trial of Proton chemoradiotherapy in NPC Patients, sponsored by Cheng-En Hsieh.

Who is sponsoring NCT07232680?

NCT07232680 is sponsored by Cheng-En Hsieh.

What drugs are being tested in NCT07232680?

Interventions in NCT07232680: Proton chemoradiotherapy, Photon chemoradiotherapy.

What condition does NCT07232680 study?

NCT07232680 studies NPC Patients, Nasopharyngeal Cancinoma (NPC).

Is NCT07232680 still recruiting?

NCT07232680 is currently recruiting now. Last updated 24 November 2025.

Last reviewed 2025-11-24 · How we verify

NCT07232680: IMPRINT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prospective Immuno-Radiomic Profiling in Nasopharyngeal Carcinoma Treated With Proton or Photon Chemoradiotherapy

Recruiting now Last updated 24 November 2025

What this trial tests

trial testing Proton chemoradiotherapy in NPC Patients in 500 participants. Currently enrolling.

Timeline

20 November 2025

Primary endpoint
15 August 2031

15 August 2034

Quick facts

Lead sponsor	Cheng-En Hsieh
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	500
Start date	20 November 2025
Primary completion	15 August 2031
Estimated completion	15 August 2034
Sites	1 location across Taiwan

Drugs / interventions tested

Proton chemoradiotherapy
Photon chemoradiotherapy

Conditions studied

NPC Patients — all drugs for NPC Patients →
Nasopharyngeal Cancinoma (NPC) — all drugs for Nasopharyngeal Cancinoma (NPC) →

Sponsor

Cheng-En Hsieh

Who can join

18 and older, any sex, with NPC Patients or Nasopharyngeal Cancinoma (NPC). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To prospectively investigate and integrate radiomic and immunologic signatures in patients with nasopharyngeal carcinoma (NPC) treated with either proton or photon radiotherapy, with the aim of identifying biomarkers associated with treatment response, toxicity, and long-term outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07232680 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cheng-En Hsieh
Last refreshed: 24 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07232680.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing